Follow
Stefan Leucht
Stefan Leucht
Prof. Dr. med., Klinik für Psychiatrie und Psychotherapie der TU-München
Verified email at lrz.tum.de
Title
Cited by
Cited by
Year
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ...
The Lancet 391 (10128), 1357-1366, 2018
29712018
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
28792013
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ...
World psychiatry 10 (1), 52, 2011
26482011
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis
The Lancet 373 (9657), 31-41, 2009
25132009
What does the PANSS mean?
S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel
Schizophrenia research 79 (2-3), 231-238, 2005
11882005
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ...
The Lancet 394 (10202), 939-951, 2019
11532019
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A …
S Leucht, G Pitschel-Walz, D Abraham, W Kissling
Schizophrenia research 35 (1), 51-68, 1999
11281999
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis
The Lancet 379 (9831), 2063-2071, 2012
10692012
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
10672011
The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis
G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel
Schizophrenia bulletin 27 (1), 73-92, 2001
10582001
Opioid antagonists for alcohol dependence
S Roesner, A Hackl‐Herrwerth, S Leucht, S Vecchi, M Srisurapanont, ...
Cochrane database of systematic reviews, 2010
9952010
Physical illness and schizophrenia: a review of the literature
S Leucht, T Burkard, J Henderson, M Maj, N Sartorius
Acta Psychiatrica Scandinavica 116 (5), 317-333, 2007
9192007
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
CU Correll, S Leucht, JM Kane
American Journal of psychiatry 161 (3), 414-425, 2004
9022004
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis
C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ...
Schizophrenia research 123 (2-3), 225-233, 2010
8532010
Clinical implications of brief psychiatric rating scale scores
S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel
The British Journal of Psychiatry 187 (4), 366-371, 2005
8422005
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
S Leucht, K Wahlbeck, J Hamann, W Kissling
The Lancet 361 (9369), 1581-1589, 2003
7802003
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis
A Cipriani, X Zhou, C Del Giovane, SE Hetrick, B Qin, C Whittington, ...
The Lancet 388 (10047), 881-890, 2016
7332016
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane
American Journal of Psychiatry 160 (7), 1209-1222, 2003
7102003
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia
S Leucht, K Komossa, C Rummel-Kluge, C Corves, H Hunger, F Schmid, ...
American Journal of Psychiatry 166 (2), 152-163, 2009
6852009
Clozapine versus other atypical antipsychotics for schizophrenia
CA Lobos, K Komossa, C Rummel‐Kluge, H Hunger, F Schmid, ...
Cochrane Database of Systematic Reviews, 2010
645*2010
The system can't perform the operation now. Try again later.
Articles 1–20